Pharmafile Logo
Pharmafocus logo
Advanced Search

New England Journal of Medicine

Showing 2 posts of 2 posts found.

Janssen’s study for nipocalimab as indicated for EOS-HDFN published in The New England Journal of Medicine

August 9, 2024
Research and Development Haematology, Janssen, New England Journal of Medicine, Obstetrics & Gynaecology, foetus, newborn, women's health

Johnson & Johnson company Janssen has announced that the results from its phase 2 trial into nipocalimab have been published …

News

Investigation questions Xarelto trial data accuracy

February 4, 2016
Medical Communications BMJ, Bayer, INR, Johnson & Johnson, New England Journal of Medicine, Rocket-AF, Xarelto, blood clotting, rivaroxaban

The ROCKET-AF trial, the pivotal trial of the top-selling anti-clotting drug Xarelto, could have been undermined by unreliable results from …

News
The Gateway to Local Adoption Series

Latest content

Equity starts with listening: putting community voices at the centre of access

September 21, 2026

Global coalition calls for stronger government action on COPD

September 18, 2026

Global health researchers call for more equitable partnerships

September 17, 2026

Liverpool launches £20m lab for infectious disease drug discovery

September 16, 2026

Circle Health Group expands into UK laboratory operations

September 15, 2026